Sorrento Therapeutics Inc (PK)
0.0115 (3.11%)

Sorrento Therapeutics Inc (PK) (SRNEQ) Fundamentals

Sorrento Therapeutics, Inc. (STI) provides access to its novel and proprietary technology platform for the construction of fully human antibody libraries, the STI Technology. The STI Technology applies RNA transcription for the amplification of human immunoglobin variable domain sequences.
Share Info
Market Cap$ 210,368,888
Shares Authorized750,000,000
Shares Outstanding551,281,154
Shares Outstanding Date03/17/2023
Shareholder Count207
Shareholder Count Date03/11/2022
Float Date-
Short Interest19,975,915
Short Interest Date02/28/2023
Reporting Info
Reporting StatusSEC Reporting
Audit StatusYes
AuditorMayer Hoffman McCann P.C.
Auditor Address11440 Tomahawk Creek Parkway
Leawood, Kansas 66211
Auditor Website-
IR Firm-
IR Firm Address-
IR Firm Website-
Legal Counsel-
Legal Counsel Address-
Legal Counsel Website-
Fiscal Year End12/31
ADR Ratio-
Transfer AgentPacific Stock Transfer Co.
Transfer Agent Address6725 Via Austi Parkway
Suite 300
Las Vegas, NV 89119
Depository Website
SHO Flag-
3210 Flag-
Company Info
Ticker SymbolUSOTC:SRNEQ
OTC Market TierPink Current
Security TypeCommon Stock
CIK Number0000850261
Address4955 Directors Place
San Diego, California 92121
Phone(858) 203-4100
Fax #858-210-3759
SIC Code / Description2836 / Biological products, except diagnostic
Key ExecutivesDir. - Scott Salka
Dir. - Diane D-S Tang-Liu
Dir. - Kim D. Janda
Chief Scientific Officer - Vuong Trieu
Chief Commercial Officer - George Uy
CFO - Richard G. Vincent
Dir. - Jane Hsiao
President - Henry Ji
Number of Employees-
Incorporation StateDelaware
Incorporation CountryUSA
Incorporation Year1989
Your Recent History
Sorrento T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20230321 18:21:51